- Home
- CCO vs CSTL Comparison
CCO vs CSTL Comparison
Compare CCO & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- CSTL
- Stock Information
- Founded
- CCO 1995
- CSTL 2007
- Country
- CCO United States
- CSTL United States
- Employees
- CCO N/A
- CSTL N/A
- Industry
- CCO Advertising
- CSTL Medical Specialities
- Sector
- CCO Consumer Discretionary
- CSTL Health Care
- Exchange
- CCO Nasdaq
- CSTL Nasdaq
- Market Cap
- CCO 586.5M
- CSTL 555.8M
- IPO Year
- CCO 2005
- CSTL 2019
- Fundamental
- Price
- CCO $1.28
- CSTL $20.84
- Analyst Decision
- CCO Hold
- CSTL Strong Buy
- Analyst Count
- CCO 5
- CSTL 6
- Target Price
- CCO $1.88
- CSTL $37.67
- AVG Volume (30 Days)
- CCO 4.0M
- CSTL 698.8K
- Earning Date
- CCO 08-05-2025
- CSTL 08-04-2025
- Dividend Yield
- CCO N/A
- CSTL N/A
- EPS Growth
- CCO N/A
- CSTL N/A
- EPS
- CCO 0.04
- CSTL N/A
- Revenue
- CCO $1,538,895,000.00
- CSTL $346,269,000.00
- Revenue This Year
- CCO $5.23
- CSTL N/A
- Revenue Next Year
- CCO $3.41
- CSTL $1.62
- P/E Ratio
- CCO $29.10
- CSTL N/A
- Revenue Growth
- CCO 31.61
- CSTL 20.40
- 52 Week Low
- CCO $0.81
- CSTL $14.59
- 52 Week High
- CCO $1.77
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CCO 62.18
- CSTL 64.07
- Support Level
- CCO $1.02
- CSTL $19.23
- Resistance Level
- CCO $1.22
- CSTL $20.80
- Average True Range (ATR)
- CCO 0.07
- CSTL 1.01
- MACD
- CCO 0.02
- CSTL 0.21
- Stochastic Oscillator
- CCO 98.08
- CSTL 81.42
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.